Alvaro
Hernandez Vicente
Centro de Investigación en Red en Enfermedades Cardiovasculares
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Centro de Investigación en Red en Enfermedades Cardiovasculares (5)
2020
-
Author Correction: Empagliflozin improves post-infarction cardiac remodeling through GTP enzyme cyclohydrolase 1 and irrespective of diabetes status (Scientific Reports, (2020), 10, 1, (13553), 10.1038/s41598-020-70454-8)
Scientific Reports
-
Empagliflozin improves post-infarction cardiac remodeling through GTP enzyme cyclohydrolase 1 and irrespective of diabetes status
Scientific Reports, Vol. 10, Núm. 1
2019
-
Galectina-3 as a biomarker of acute kidney injury risk in patients with decompensated heart failure
Revista Clinica Espanola, Vol. 219, Núm. 6, pp. 315-319
-
Population-based Study of First Hospitalizations for Heart Failure and the Interaction Between Readmissions and Survival
Revista Espanola de Cardiologia, Vol. 72, Núm. 9, pp. 740-748
-
The Interleukin-1 Axis and Risk of Death in Patients With Acutely Decompensated Heart Failure
Journal of the American College of Cardiology, Vol. 73, Núm. 9, pp. 1016-1025